Some aspects of the dopaminergic action of ergot derivatives and their role in the treatment of migraine.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001971:Bromocriptine / Q000494:pharmacology; D004879:Ergotamines / Q000494:pharmacology*; D005260:Female; D006801:Humans; D008090:Lisuride / Q000494:pharmacology; D008711:Metergoline / Q000494:pharmacology; D008784:Methysergide / Q000494:pharmacology; D008881:Migraine Disorders / Q000188:drug therapy*; D009474:Neurons / Q000187:drug effects; D010902:Pituitary Gland / Q000187:drug effects; D011388:Prolactin / Q000378:metabolism; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects*; D011985:Receptors, Serotonin / Q000187:drug effects; D012702:Serotonin Antagonists / Q000494:pharmacology
D004879:Ergotamines; D011954:Receptors, Dopamine; D011985:Receptors, Serotonin; D012702:Serotonin Antagonists; D008711:Metergoline; D001971:Bromocriptine; D011388:Prolactin; D008090:Lisuride; D008784:Methysergide